CHATTANOOGA 5000022Recalls & reported problems

Djo, LLC · Iogel Medium 2.5 cc electrode, Box of 12 · Class 2

All models of CHATTANOOGA (39)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports: 1
Deaths reported: 0
Injuries reported: 1
Recalls naming it: 0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00888912151412), received between Nov 5, 2020 and Nov 5, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

Adverse Event Without Identified Device or Use Problem1

Patient problems

Burn(s)1
Full thickness (Third Degree) Burn1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

InjuryNov 5, 2020Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE "ELECTRODES BURNED A PATIENT AND TWO SMALL BLISTERS THAT PROGRESSED TO A THIRD DEGREE BURN." THE DEVICE HAS NOT BEEN RETURNED FOR EVALUATION. THERE IS NO ADDITIONAL INFORMATION AVAILABLE AT THIS TIME.
Patient problems: Burn(s); Full thickness (Third Degree) Burn
MAUDE report 10791192 ↗

Device details

UDI-DI	`00888912151412`
Brand	CHATTANOOGA
Model	5000022
Company	Djo, LLC
Product code	EGJ · Device, Iontophoresis, Other Uses
Class	Class 2
FDA submission	None listed
Implant	No
Rx / OTC	—
Single use	Yes
Sterile	No
MRI safety	Labeling does not contain MRI Safety Information
Status	In Commercial Distribution
Record updated	Aug 23, 2024

Device type (GMDN): Drug-delivery iontophoresis system electrode, active

A dedicated, active, electrical conductor that is a component of an iontophoresis system for transcutaneous drug delivery of a localized medication (e.g., corticosteroids or local anaesthetics). It is typically a layered pad that is attached to the skin surface of the patient at the target site, and connected to the current generator with a lead wire. An applied electric field causes the ionic-solution medication to transport from a reservoir within the pad for patient exposure. It comes in a variety of sizes. This is a single-use device.

Other Device, Iontophoresis, Other Uses devices

IontoPatch 80
LTS Therapy Systems, LLC · Device, Iontophoresis, Other Uses
1 recall0 reports
IontoPatch STAT
LTS Therapy Systems, LLC · Device, Iontophoresis, Other Uses
1 recall0 reports
ActivaPatch 001-40
Activatek Inc. · Device, Iontophoresis, Other Uses
1 report
ActivaPatch IontoGo 4.0 001-50
Activatek Inc. · Device, Iontophoresis, Other Uses
1 report

All Device, Iontophoresis, Other Uses devices →

Sources and updates

Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.

How reports and recalls are matched · Editorial policy · Report an error on this page